The 1 Thing I'll be Looking for in Moderna's Earnings Report Next Week

The 1 Thing I'll be Looking for in Moderna's Earnings Report Next Week
·4 min read

Moderna's (NASDAQ: MRNA) last earnings report was chock-full of good surprises. The company announced its first-ever profit, which surpassed $1 billion, thanks to Moderna's single product: the coronavirus vaccine. The company expects more than $19 billion in vaccine sales this year and reported progress on vaccine orders for next year, too.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting